SAANS is an India based Medical Technology Startup, committed at developing cheap and affordable medical innovations projects for the critical unmet needs, the initial six-months were spent undergoing clinical immersion at tertiary care hospitals, ambulances and peripheral care settings, as a result of which, the product “Saans” was formulated.
Saans is a low cost and easy to use mechanical Continuous Positive Airway Pressure (CPAP) device, which is used to maintain a constant pressure, and constant air flow to keep the lungs of newborns and infants open during troubled breathing. Saans is vital for continuous breathing support for infants with troubled breathing during transportation to advanced care facilities and in temporary maintenance of respiratory support in instances where electric CPAP machines cannot work. The product being an entirely mechanical assembly operates without any power and could be used by an untrained person (usually parents/relatives) without any external supervision from a trained medical professional unlike electric CPAP machines. Saans will provide high quality, low skill respiratory support at a lesser cost.
The business model adopted by this producer organization is strengthening of weaver base by collectivization and integrating the entire value chain involved in the handloom process. Since member weavers are the decision making authority for every activity in the weaving value chain, the margins added during each level due to the value addition goes to the weavers and members working for the producer company.
The key activities in the value chain process are:
Currently, 45% of the world’s population lives in societies with highly skewed male to female ratios. Sex selective abortion occurs at highest rates in China, Armenia, India, Albania, Vietnam, Azerbaijan, Georgia, and South Korea. Such an imbalance in sex ratios further decreases the status of women in society. Female foeticide or the killing of female baby still in her mother’s womb is the primary reasons for such skewedness. 95% of pre-natal sex-detection occurs via the use of an ultrasound machine which serves as a facilitator for female foeticide.
Ultrasafe Ultrasound uses a patented technology that automatically prevents the identification of genitalia in live images produced by ultrasound machines. The technology uses customized image recognition software that detects and censors the foetal genitalia in ultrasound images thus preventing discerning of the gender of the child. The “Ultrasafe Ultrasound Box” can be retrofitted into existing sonography machines. The removal gender recognition capability from ultrasound machines will facilitate removal of strict licensing and monitoring norms imposed by the Indian Government enabling faster growth and penetration of ultrasound imaging technology in India and also removal of ban imposed on sale of portable ultrasound machines in India.